Guidance

Widening the availability of naloxone

Explains regulations that widen the availability of naloxone, a drug used as an antidote for heroin (or other opiate) overdoses.

From:
Department of Health and Social Care and Medicines and Healthcare products Regulatory Agency
Published
10 November 2015
Last updated
18 February 2019 — See all updates

Documents

Widening the availability of naloxone

HTML

Details

Regulations introduced in 2015 and amended in 2019 widened the availability of naloxone, a medicine which reverses the effects of a heroin (or other opiate) overdose. This information explains the regulations and how they can be implemented.

Updates to this page

Published 10 November 2015
Last updated 18 February 2019 + show all updates

  1. Updated guidance to include use of nasal naloxone.

  2. Revised guidance on widening the availability of naloxone, to reflect its increased availability since 2015 legislation.

  3. Updated to include section 5.1 on supply of naloxone to children and young people.

  4. First published.

Sign up for emails or print this page

Related content